Showing 1 - 20 results of 27 for search 'O. V. Averkov', query time: 0.03s Refine Results
  1. 1
    IDEAL DOSE OF ACETYLSALICYLIC ACID FOR CARDIAC PATIENTS: THE SEARCH IS OVER?

    IDEAL DOSE OF ACETYLSALICYLIC ACID FOR CARDIAC PATIENTS: THE SEARCH IS OVER? by O. V. Averkov

    Published 2011-08-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    APPLICATION OF RIVAROXABAN IN ACUTE CORONARY SYNDROME: EVIDENCE AND CURRENT GUIDELINES

    APPLICATION OF RIVAROXABAN IN ACUTE CORONARY SYNDROME: EVIDENCE AND CURRENT GUIDELINES by O. V. Averkov

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Early discontinuation of dual antiplatelet therapy via acetylsalicylic acid cessation in patients with acute coronary syndrome undergoing percutaneous coronary interventions to reduce the bleeding risk

    Early discontinuation of dual antiplatelet therapy via acetylsalicylic acid cessation in patients with acute coronary syndrome undergoing percutaneous coronary interventions to red... by O. V. Averkov

    Published 2021-02-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Clopidogrel in the treatment of patients with ST-elevation acute myocardial infarction: state-of-art in 2013

    Clopidogrel in the treatment of patients with ST-elevation acute myocardial infarction: state-of-art in 2013 by O. V. Averkov

    Published 2013-02-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    ACETYLSALICYLIC ACID AND PREVENTION OF FATAL OUTCOMES IN CARDIOVASCULAR DISEASE: SELECTING MEDICATION FORM AND DOSE

    ACETYLSALICYLIC ACID AND PREVENTION OF FATAL OUTCOMES IN CARDIOVASCULAR DISEASE: SELECTING MEDICATION FORM AND DOSE by O. V. Averkov

    Published 2012-08-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    BIVALIRUDIN AND PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME: THEORY AND PRACTICE

    BIVALIRUDIN AND PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME: THEORY AND PRACTICE by O. V. Averkov

    Published 2012-06-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Acetylsalicylic acid as an anti-platelet agent: what forms should be used, according to evidence-based medicine?

    Acetylsalicylic acid as an anti-platelet agent: what forms should be used, according to evidence-based medicine? by O. V. Averkov

    Published 2010-04-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Ticagrelor and thrombolysis in myocardial infarction: what does the TREAT study change?

    Ticagrelor and thrombolysis in myocardial infarction: what does the TREAT study change? by O. V. Averkov, V. I. Vechorko

    Published 2018-09-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Gastrointestinal Bleeding: a Cardiologist's Point of View

    Gastrointestinal Bleeding: a Cardiologist's Point of View by O. V. Averkov, L. N. Mishchenko

    Published 2021-11-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Selection of P2Y12 antagonist in patients with myocardial infarction who received thrombolytic therapy. Results of annual follow-up of TREAT study patients

    Selection of P2Y12 antagonist in patients with myocardial infarction who received thrombolytic therapy. Results of annual follow-up of TREAT study patients by O. V. Averkov, V. I. Vechorko

    Published 2019-09-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    New SARS-CoV-2 Omicron variant — clinical picture, treatment, prevention (literature review)

    New SARS-CoV-2 Omicron variant — clinical picture, treatment, prevention (literature review) by V. I. Vechorko, O. V. Averkov, A. A. Zimin

    Published 2022-07-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    THE PLACE FOR SYSTEMIC THROMBOLYSIS IN MODERN REPERFUSION METHODS FOR MYOCARDIAL INFARCTION

    THE PLACE FOR SYSTEMIC THROMBOLYSIS IN MODERN REPERFUSION METHODS FOR MYOCARDIAL INFARCTION by O. V. Averkov, E. P. Pavlikova, E. E. Tyulkina

    Published 2014-09-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Venous thromboembolism in patients with heart failure

    Venous thromboembolism in patients with heart failure by O. V. Averkov, I. V. Shevchenko, T. Sh. Mirilashvili, Zh. D. Kobalava

    Published 2011-08-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    NEWS2, 4C Mortality Score, COVID-GRAM, Sequential Organ Failure Assessment Quick scales as outcomes assessment tools for severe COVID-19 (pilot retrospective cohort study)

    NEWS2, 4C Mortality Score, COVID-GRAM, Sequential Organ Failure Assessment Quick scales as outcomes assessment tools for severe COVID-19 (pilot retrospective cohort study) by V. I. Vechorko, O. V. Averkov, D. V. Grishin, A. A. Zimin

    Published 2022-03-01
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    COVID-19 infection after recent heart transplantation: a case report

    COVID-19 infection after recent heart transplantation: a case report by V. I. Vechorko, I. G. Gordeev, E. V. Gubareva, E. V. Ryndyaeva, O. V. Averkov

    Published 2020-06-01
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    SUMMARY OF CONCLUSIONS FROM A CONSENSUS PANEL OF EXPERTS ON THE IMPORTANCE OF RIVAROXABAN IN THE MANAGEMENT OF PATIENTS RECOVERING FROM ACUTE CORONARY SYNDROME

    SUMMARY OF CONCLUSIONS FROM A CONSENSUS PANEL OF EXPERTS ON THE IMPORTANCE OF RIVAROXABAN IN THE MANAGEMENT OF PATIENTS RECOVERING FROM ACUTE CORONARY SYNDROME by M. Ya. Ruda, A. I. Syrkin, E. P. Panchenko, I. S. Yavelov, O. V. Averkov, R. M. Shahnovich, A. L. Komarov

    Published 2015-12-01
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    RANDOMIZED COMPARISON OF TWO APPROACHES TO WARFARIN DOSAGE IN CARDIOVASCULAR HOSPITAL SECTION

    RANDOMIZED COMPARISON OF TWO APPROACHES TO WARFARIN DOSAGE IN CARDIOVASCULAR HOSPITAL SECTION by L. N. Mishchenko, O. V. Averkov, I. G. Gordeev, E. E. Tyulkina, E. P. Pavlikova, N. N. Levchuk, I. G. Pletnikova

    Published 2015-08-01
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    The Effect of Carriage of <i>CYP3A5*3</i> and <i>CYP3A4*22</i> Polymorphic Variants on the Safety of Remdesivir Therapy in Patients with COVID-19

    The Effect of Carriage of <i>CYP3A5*3</i> and <i>CYP3A4*22</i> Polymorphic Variants on the Safety of Remdesivir Therapy in Patients with COVID-19 by I. I. TEMIRBULATOV, A. V. KRYUKOV, K. B. MIRZAEV, N. P. DENISENKO, S. P. ABDULLAEV, A. S. ZHIRYAKOVA, Y. V. SHEVCHUK, V. I. VECHORKO, O. V. AVERKOV, D. A. SYCHEV

    Published 2022-11-01
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    Pharmacogenetic aspects of the effectiveness of nonsteroidal anti-inflammatory drugs and opioids for postoperative pain management in patients after total joint arthroplasty

    Pharmacogenetic aspects of the effectiveness of nonsteroidal anti-inflammatory drugs and opioids for postoperative pain management in patients after total joint arthroplasty by A. S. Zhiryakova, N. P. Denisenko, S. N. Tuchkova, A. S. Petrukhina, A. V. Kryukov, I. V. Sychev, K. B. Mirzaev, O. V. Averkov, V. I. Vechorko, E. O. Filatov, D. A. Sychev

    Published 2020-12-01
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    Pharmacogenetic aspects of the efficacy of nonsteroidal anti-inflammatory drugs and opioid analgesics for postoperative pain relief after total joint arthroplasty

    Pharmacogenetic aspects of the efficacy of nonsteroidal anti-inflammatory drugs and opioid analgesics for postoperative pain relief after total joint arthroplasty by A. S. Zhiryakova, N. P. Denisenko, S. N. Tuchkova, A. S. Petrukhina, A. V. Kryukov, I. V. Sychev, K. B. Mirzaev, O. V. Averkov, V. I. Vechorko, E. O. Filatov, D. A. Sychev

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: